Furthermore, a Kaplan-Meier analysis demonstrated that patients with elevated TIMMDC1 expression had significantly shorter cancer-related survival times than those with low TIMMDC1 expression in the TMA cohort (Log-rank test, P = 0.0094) (Figure 4D). This evidence concerns the gene TIMMDC1 and cancer.